Clinical Trials in France / NCT07645872
Recruiting
Observational
Clinical Data Collection of Patients Treated With High Intensity Focused Ultrasound (HIFU) by the Focal One for Their Prostate Cancer.
NCT07645872 · tracked via the Priya Life Science France tracker
Condition(s) studied
Prostate Cancer
Study summary
The aim of the registry is to gather real-life data to evaluate the clinical performance and safety of medical devices in patients who have been treated with HIFU thank to the Focal One device for their prostate cancer.
Eligibility
Inclusion Criteria:
* Being treated for prostate cancer with the Focal One device
* Patient does not object and consent\* to the collection of clinical data in the registry
Exclusion Criteria:
* Patient deprived of liberty following a judicial or administrative decision
* Patient under guardianship or curatorship \* if applicable according to local regulation
Primary outcome measure(s)
- To monitor the safety of HIFU treatment with the Focal One in patients treated for prostate cancer. — From HIFU treatment up to 5 years post-HIFU
Safety will be assessed by collecting adverse events related to HIFU treatment.
Trial sites (5)
| Facility | City | Region | Status |
|---|---|---|---|
| Hôpital privé Aix en provence | Aix-en-Provence | France | Recruiting |
| Clinique Saint vincent | Besançon | France | Recruiting |
| Hôpital Civil Colmar | Colmar | France | Recruiting |
| Hôpital Edouard Heriot | Lyon | France | Recruiting |
| Clinique Nantes Atlantis | Nantes | France | Recruiting |
More EDAP TMS S.A. trials in France
Evaluation of the Efficacy of HIFU Treatment on Rectal Endometriosis Symptoms.
Active, not recruiting
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07645872 on ClinicalTrials.gov ↗ ← All trials in France